We defend healthcare providers, practices, and clinics against Criminal and Civil Healthcare Matters, Medicare & Medicaid Investigations, PBM audits and UPIC Recoupment Demands, DEA Inspections, Board of Pharmacy Hearings, FDA Enforcement Actions, and Compounding Cases, across all 50 states.
"Top-notch attorneys with an unparalleled scope of experience and breadth of knowledge. You will want them in your corner."
Speak directly to an attorney with subject matter expertise
Defend against OptumRx, CVS Caremark, Express Scripts, Humana, and Prime audits. Recoupment reductions, network reinstatements, federal litigation when the PBM refuses resolution.
Reverse PBM termination for cause and reinstate pharmacies into the OptumRx, UnitedHealthcare, Aetna, ESI, Humana, and Prime networks. 7-NY pharmacy reinstatement anchor.
OptumRx-specific audit defense. Operational expertise from inside the network (Anthony Mahajan was Chief Compliance Officer of UnitedHealth Group, OptumRx's parent). $4.7M recoupment reduced to $180K.
Federal healthcare fraud defense across DOJ Civil and Criminal, HHS-OIG, FBI, DEA, the state Medicaid Fraud Control Units, and state licensing boards.
Qui tam relator suits, Civil Investigative Demands, and DOJ Civil Division investigations. Anchored on a Rule 9(b) particularity dismissal of an oncology FCA matter at the pleading stage.
DEA defense for pharmacies, distributors, manufacturers, and importers. Order to Show Cause proceedings and suspicious order monitoring (SOM). Led by a 32-year DEA Diversion veteran.
503A pharmacy and 503B outsourcing facility defense. FDA inspections, DQSA enforcement, GLP-1/peptide compounding, USP 797 sterility. Led by a pharmacist-attorney with 200+ FDA publications.
Umbrella for UPIC, RAC, MAC, SMRC, and CERT contractor audit defense. The 5-level Medicare appeals track from redetermination to federal court.
State Board of Pharmacy complaints, inspections, disciplinary hearings, and license defense for pharmacies and pharmacists - coordinated with any parallel PBM, DEA, or Medicaid matter.
FDA inspections, Form 483 responses, Warning Letters, and DQSA compounding enforcement for 503A pharmacies and 503B outsourcing facilities.
Patent disputes, brand-manufacturer lawsuits, and essentially-copies allegations against compounded preparations. Bench includes a registered patent attorney.
DOJ
FBI
HHS-OIG
IRS
NAMFCU
DEA
McKesson
OptumRx
"I spent nine years prosecuting healthcare cases for the DOJ. Then I ran compliance for the largest healthcare company in America. Now I use what I learned on both sides to defend the people being investigated."
After leaving the U.S. Attorney's Office, I served as Chief Compliance Officer at UnitedHealth Group and Chief Counsel at McKesson - overseeing legal operations for companies generating hundreds of billions in revenue. I founded Health Law Alliance because pharmacies, physicians, and healthcare companies deserve defense counsel who genuinely understand how PBMs build audit cases, how DOJ prosecutors decide what to charge, and how the DEA evaluates registrants. We know - because we used to do it.
Former federal and state prosecutors and fraud investigators from UnitedHealth, OptumRx, Qlarant, and McKesson — now defending the cases they used to investigate and prosecute
Get My Free Case ReviewOur team includes the former Chief Compliance Officer for UnitedHealth Group over Optum and United Healthcare, Qlarant UPIC fraud investigator, DOJ and Attorney General prosecutors, and 32-year DEA Diversion Program Manager, who understand enforcement from every side of the table.
Our attorneys are specialists in their fields and bring that focus to solve recurring industry challenges.
We employ mission-driven healthcare provider-attorneys who deeply understand the industry and its challenges.
Over 2,000 audits or investigations handled, with documented wins including dismissed federal and state charges, millions in recoupments overturned, and network terminations reversed.
DOJ dismissed its entire case against a NJ physician - the lone dismissal among 35 related prosecutions.
All seven OptumRx terminations reversed in a single coordinated appeal.
$4.7M OptumRx demand reduced to $180K - a 96% reduction on appeal.
Speak with an experienced attorney today at no cost - evaluate your situation and learn how we can help. Confidential, no obligation.